Innovate UK
Innovate UK EDGE’s highly regarded Scaleup Programme provides oneto-one, bespoke and fully funded support centered around innovative scaleups’ specific needs. It is available to those companies achieving, or with the potential for, 50% compound annual growth rates (CAGR) and over.
The Scaleup Programme helps the highest potential businesses realise their ambitions. Delivering growth at scale is at the heart of Innovate UK’s emerging strategy for business innovation in the UK. Innovate UK EDGE is a key enabler of this strategic priority and through the Scaleup Programme, helps the highest potential businesses realise their ambitions.
Deadline: None specified
Funding: Not specified
NIHR
The EME Programme primarily supports clinical trials, and other robustly designed studies that test the efficacy of interventions. The interventions should have the potential to improve patient care or benefit the public. The programme will only support studies where there is sufficient evidence that the intervention might work in man, i.e. that there is ‘proof of concept’. Current calls here include Cystic Fibrosis, Novel strategies to reduce overtreatment, Paediatric Care among others.
Latest guidance: Efficacy and Mechanism Evaluation (EME) | NIHR
- NIHR NICE rolling funding opportunity (EME Programme)
Deadline: 5 August 2025 at 1:00 pm
- NIHR James Lind Alliance Priority Setting Partnerships rolling funding opportunity (EME Programme)
Deadline: 5 August 2025 at 1:00 pm
Funding: Discretionary
The Health Technology Assessment (HTA) Programme funds research about the clinical and cost-effectiveness and broader impact of healthcare treatments and tests for those who plan, provide or receive care from NHS and social care services. They have a number of themed calls, please refer their website for more information.
Latest guidance: Health Technology Assessment (HTA) | NIHR
- HTA Post-Doctoral Award
Deadline: 30 July 2025 at 1:00 pm
- Compensatory interventions to facilitate swallowing in adults with dysphagia to fluids
Deadline: 30 July 2025 at 1:00 pm
Funding: Discretionary
Other opportunities
BHF provide personal support for clinical and non-clinical cardiovascular researchers at all stages of their career. They also provide grants for short and long term research projects, essential infrastructure and strategic initiatives.
A range of different grants are offered.
Please see the latest guidance/deadlines.
Deadline: None specified
Funding: Not available
The Global Innovation Fund is a non-profit innovation fund headquartered in London with an office in Washington D.C. that invests in the development, rigorous testing, and scaling of innovations targeted at improving the lives of the world’s poorest people. Through our grants and risk capital, we help breakthrough solutions to global development challenges from for profit firms, non profit organisations, researchers, and government agencies to maximise their impact and affect meaningful change.
Please see the latest guidance/deadlines
Deadline: None specified
Funding: Discretionary
Nesta Impact Investments is a £17.6m fund investing in life changing innovations that help tackle the major challenges faced by older people, children and communities in the UK.
Please see the latest guidance/deadlines
Deadline: None specified
Funding: Up to £1,000,000